24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Tarsius Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:14
Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program
19:40
Greece approves $750M rocket deal with Elbit amid negotiations for $3.5B Israeli air-defense systems
19:09
Intel VP: “We’re just not going to accept subpar products”
10:39
Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff
More stories
Buzz
Most popular
Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Nice puts Actimize up for sale at a $1.5-2 billion price tag
3
Zafran raises $60 million and doubles valuation as it chooses independence over takeover offers
4
Israeli drone startup Heven hits $1 billion valuation in $100 million round led by IonQ
5
Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program
More news
Tarsius Pharma
1 stories about Tarsius Pharma
Tarsius Pharma Receives 2.4 Million Euros EU Grant to Combat Blinding Diseases
18.09.19
|
Adi Pick
The company intends to use the funding to start clinical development of its technology